Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009;13(2):209.
doi: 10.1186/cc7701. Epub 2009 Apr 22.

Bench-to-bedside review: Optimising emergency reversal of vitamin K antagonists in severe haemorrhage - from theory to practice

Bernard Vigué  1
Affiliations
Review

Bench-to-bedside review: Optimising emergency reversal of vitamin K antagonists in severe haemorrhage - from theory to practice

Bernard Vigué. Crit Care. 2009.

Abstract

Critical care physicians are increasingly facing patients receiving oral anticoagulation for either cessation of major haemorrhage or to reverse the effects of vitamin K antagonists ahead of emergency surgery. Rapid reversal of anticoagulation is particularly essential in cases of life-threatening bleeding. In these situations, guidelines recommend the concomitant administration of prothrombin complex concentrates (PCCs) and oral or intravenous vitamin K for the fastest normalisation of the international normalised ratio (INR). Despite their universal recommendation, PCCs remain underused by many physicians who prefer to opt for fresh frozen plasma despite its limitations in anticoagulant reversal, including time to reverse INR and high risk of transfusion-related acute lung injury. In contrast, the lower volume required to normalise INR with PCCs and the room temperature storage facilitate faster preparation and administration time, thus increasing the speed at which haemorrhages can be treated. PCCs therefore allow faster, more reliable and complete reversal of vitamin K anticoagulation, especially when administered immediately following confirmation of haemorrhage. In the emergency setting, probabilistic dosing may be considered.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cumulative bleeding of patients receiving warfarin [5]. Reproduced with permission from Lippincott Williams & Wilkins ()
Figure 2
Figure 2
Calculation of prothrombin complex concentrate dose for anticoagulant reversal in bleeding patients [2]. The proposed 'calculation of dose' method is difficult to manage in an emergency situation when immediate normalisation of the international normalised ratio (INR) is required to stop life-threatening bleeding. Reproduced with permission from Massachusetts Medical Society.
Figure 3
Figure 3
Algorithm for anticoagulant reversal with prothrombin complex concentrates. INR, international normalised ratio; PCC, prothrombin complex concentrate.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Makris M, Watson HG. The management of coumarin-induced overanticoagulation annotation. Br J Haematol. 2001;114:271–280. doi: 10.1046/j.1365-2141.2001.02908.x. - DOI - PubMed
    1. Schulman S. Clinical practice. Care of patients receiving long-term anticoagulant therapy. N Engl J Med. 2003;349:675–683. doi: 10.1056/NEJMcp025373. - DOI - PubMed
    1. Wittkowsky AK, Devine EB. Frequency and causes of overanticoagulation and underanticoagulation in patients treated with warfarin. Pharmacotherapy. 2004;24:1311–1316. doi: 10.1592/phco.24.14.1311.43144. - DOI - PubMed
    1. Samsa GP, Matchar DB, Goldstein LB, Bonito AJ, Lux LJ, Witter DM, Bian J. Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Intern Med. 2000;160:967–973. doi: 10.1001/archinte.160.7.967. - DOI - PubMed
    1. Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation. 2007;115:2689–2696. doi: 10.1161/CIRCULATIONAHA.106.653048. - DOI - PubMed

Publication types

MeSH terms